|
| Human KRAS G12V (HLA-A*11:01) Protein (LTP10262) |
|
| LTP10262 |
|
| 100ug |
|
|
$406 In stock |
| Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. |
| Recombinant Human KRAS G12V (HLA-A*11:01) Protein is expressed from Expi293 with His tag and Avi tag at the C-terminal. It contains Gly25-Thr305(HLA-A*11:01),Ile21-Met119(B2M) and VVVGAVGVGK peptide. |
|
| KRAS G12V (HLA-A*11:01) |
|
| Human |
|
| AAV53343.1(HLA-A*11:01)&P61769(B2M)&VVGAVGVGK |
|
| Gly25-Thr305(HLA-A*11:01),Ile21-Met119(B2M)and VVVGAVGVGK peptide |
|
| The protein has a predicted MW of 50.3 kDa. Due to glycosylation, the protein migrates to 51-60 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| C-His-Avi |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
